Literature DB >> 16085447

Fulminant hepatic failure following halothane anaesthesia.

G Pradeep Kumar1, Vrinda J Bhat, Vasantha Sowdi.   

Abstract

The forensic pathologist is responsible for determining the cause, manner and approximate time of death and injury. After recording the detailed description of the external and internal appearances, a short summary should be offered of the major positive findings and their relationship to the cause of death. In many cases this will be obvious, however when the findings are less clear-cut, or are multiple, then the alternatives should be discussed detailing the possible sequence of events and interpreting the findings in concluding the cause of death. It is essential to causally connect the autopsy findings to the cause of death. We present a case report wherein a person who sustained avulsion injury to his left hand in an industrial accident, died due to, fulminant hepatitis, hepatic encephalopathy and acute renal failure, having undergone six operations under general anesthesia with halothane during his stay in the hospital.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085447     DOI: 10.1016/j.jcfm.2004.10.019

Source DB:  PubMed          Journal:  J Clin Forensic Med        ISSN: 1353-1131


  3 in total

1.  A mouse model of severe halothane hepatitis based on human risk factors.

Authors:  Christine M Dugan; Allen E MacDonald; Robert A Roth; Patricia E Ganey
Journal:  J Pharmacol Exp Ther       Date:  2010-02-02       Impact factor: 4.030

2.  Halothane hepatitis in Iran: a review of 59 cases.

Authors:  Payam Eghtesadi-Araghi; Amirali Sohrabpour; Homayoon Vahedi; Mehdi Saberi-Firoozi
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

3.  Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis.

Authors:  Peiman Habibollahi; Nastaran Mahboobi; Sara Esmaeili; Saeid Safari; Ali Dabbagh; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.